PExI
This core metric managed closely by PSP reflects the extent to which patients take their medication as prescribed
What is Adherence?
These two key tools are used by the HEOR team to help develop a compelling Value story for payers
What are economic models and budget impact analyses?
The pricing team manages submission to this authority that governs and enforces compliance for our list prices
What is the PMPRB?
The field team is the point of contact for discussions with their customers about this document that outlines terms and conditions for our products.
What is PLA?
The two main external stakeholders that the Patient Access Leads engage with to ensure payers understand the true value of our products
Who are HCPs and PAGs?
The name of the critical internal committee that the PSP brand leads engage to approve NVS PSP launches or modifications.
What is PSPOC?
This HEOR customer does not allow for a Reconsideration once a Recommendation is issued
What is INESSS submission?
The governance tool used by V&A to approve prices.
What is PricePro?
The field team relies on this document to outline contract terms for their customers for public formulary listings.
What is pCPA LOI?
The patient access strategy team is responsible for leading V&A input into this important regional review process for launch products
What are LRRs (launch readiness reviews)?
This platform built and managed by the innovation team serves is the single entry point that guides teams through evaluating, approving, and implementing innovation projects.
What is Innovation Front Door?
HEOR customers typically use these thresholds to determine cost effectiveness
What are 50k and 100k/QALY?
The pricing team works closely with these two functions in reviewing and approving payer contracts
What is PSP, Legal, Access Strategy?
The private payer and PSP team rely on this form to determine what if any clinical criteria must be met before private payer coverage is granted.
What is prior authorization/special authorization?
This process that precedes the HTA submission is a critical milestone for the patient access strategy and HEOR teams
What is the stakeholder input process/ window?
In PSP, a dedicated team manages this process that adjusts previously dispensed claims so a payer can cover a dose that was previously free.
What is retrobilling?
HEOR relies on this internal NVS process to identify missing data for payer submissions enabling closing these gaps
What is integrated evidence planning?
Two critical activities the pricing team performs daily
What is invoice validation, contract management, adherence to pricing regulations/guidance, and access analytics?
This performance indicator is a key measure to ensure appropriate inventory levels at wholesalers and avoid peaks and valleys in sales
What is Stock in Trade?
A critical tool for the Patient Access Strategy team when negotiations stall
What is external/ stakeholder advocacy?
This major private payer does not permit back dating SAs and thus limits retro billing opportunities.
What is Sunlife?
HEOR uses this tool to provide comparative clinical information when head to head data is not available.
What are indirect treatment comparisons?
The pricing team is working on this critical initiative that integrates financial reporting and ordering.
What is LDC? Lean data core
The most important stakeholder in the public system for the field V&A team.
Who is the drug plan lead/ drug plan manager?
The patient access, pricing and field access teams collaborated seamlessly to take advantage of this industry first accelerated access initiative
What is FAST (funding accelerated for specific treatments)?